Teriparatide as an Adjunct in Managing Delayed Union of Long Bone Fractures: Insights from a Tertiary Care Center
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_291_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Ravindra Mohan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, King George's Medical University, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Teriparatide, Fracture Healing, Bone Density Conservation Agents, Fractures, Bone. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Delayed union of long bone fractures presents a significant clinical challenge, often leading to prolonged morbidity and functional limitation. Teriparatide, a recombinant human parathyroid hormone (PTH 1–34), has shown promise as a biological enhancer of bone healing. This study aims to evaluate the efficacy and safety of teriparatide in promoting fracture healing in patients with delayed union. Materials and Methods: A prospective interventional study was conducted on 48 adult patients (mean age: 42.6 ± 11.2 years) with delayed union of long bone fractures (tibia, femur, humerus, and radius/ulna) between 3 and 9 months postinjury. All patients received daily subcutaneous teriparatide (20 μg) for 3 months, along with calcium and vitamin D supplementation. Clinical outcomes were assessed using the Visual Analog Scale (VAS) and weight-bearing ability; radiological healing was assessed using the Radiographic Union Score for Tibial fractures (RUST) and cortical bridging on serial radiographs at 0, 6, and 12 weeks.
Results
The mean VAS score significantly reduced from 7.8 ± 1.1 at baseline to 2.1 ± 0.9 at 12 weeks ( P < 0.001). Radiological union was observed in 81.2% of patients at 12 weeks, with the mean RUST score improving from 5.2 ± 1.3 to 10.3 ± 1.2 ( P < 0.001). Clinical union was achieved in 87.5% of patients, and 91.7% regained full weight-bearing ability. Metaphyseal fractures and fractures with stable fixation showed better outcomes. No major adverse events were reported.
Conclusion
Teriparatide is a safe, well-tolerated, and effective adjunct in managing delayed union of long bone fractures. It accelerates both clinical and radiological healing, reducing the need for surgical reintervention. These findings support its inclusion in the orthopedic treatment armamentarium for biologically enhancing fracture repair in selected cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, King George's Medical University, Lucknow, Uttar Pradesh, India.
Zitieren
APA
Mohan, R., Singh, S., Manral, N., Kumar, A., Patel, B. M., Kannaujiya, M., & Chaudhary, S. K. (2026). Teriparatide as an Adjunct in Managing Delayed Union of Long Bone Fractures: Insights from a Tertiary Care Center. Annals of African Medicine. https://doi.org/10.4103/aam.aam_291_25
Vancouver
Mohan R, Singh S, Manral N, Kumar A, Patel BM, Kannaujiya M, et al. Teriparatide as an Adjunct in Managing Delayed Union of Long Bone Fractures: Insights from a Tertiary Care Center. Annals of African Medicine. 2026. doi:10.4103/aam.aam_291_25
BibTeX
@article{Mohan2026,
author = {Mohan, Ravindra and Singh, Shailendra and Manral, Nitin and Kumar, Amit and Patel, Brij Mohan and Kannaujiya, Mithilesh and Chaudhary, Sujeet Kumar},
title = {Teriparatide as an Adjunct in Managing Delayed Union of Long Bone Fractures: Insights from a Tertiary Care Center},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_291_25}
}
EUVIMED